Loading...
Loading...
MLAB| Name | Value |
|---|---|
| Revenues | 58.7M |
| Cost of Revenue | 22.4M |
| Gross Profit | 36.4M |
| Operating Expense | 32.4M |
| Operating I/L | 4.0M |
| Other Income/Expense | -0.6M |
| Interest Income | 1.2M |
| Pretax | 3.4M |
| Income Tax Expense | 2.1M |
| Net Income/Loss | 1.3M |
Mesa Laboratories, Inc. operates in four segments. The Sterilization and Disinfection Control segment manufactures and sells indicators for assessing sterilization and disinfection processes. The Biopharmaceutical Development segment offers automated systems for protein analysis and peptide synthesis solutions. The Calibration Solutions segment designs and markets quality control and calibration products for health and safety purposes. The Clinical Genomics segment develops genetic analysis tools for clinical testing in therapeutic areas. The company generates revenue by selling biological, cleaning, and chemical indicators, protein analysis equipment, calibration products, and genetic analysis tools.
